Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:58 AM UTC
| NCT Number | NCT06697301 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 740 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Eikon Therapeutics |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT06697301 is currently recruiting participants. This phase2 study for melanoma is actively seeking new participants at 14 locations across the United States. The study is sponsored by Eikon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06697301 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06697301 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.